Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF

被引:97
作者
Spear, Paul [1 ]
Barber, Amorette [1 ]
Rynda-Apple, Agnieszka [1 ]
Sentman, Charles L. [1 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
基金
美国国家卫生研究院;
关键词
COLONY-STIMULATING FACTOR; NF-KAPPA-B; OVARIAN-CANCER; INTERFERON-GAMMA; DENDRITIC CELLS; MACROPHAGE POLARIZATION; MONONUCLEAR PHAGOCYTES; ANTITUMOR IMMUNITY; STAT1; ACTIVATION; IL-10; PRODUCTION;
D O I
10.4049/jimmunol.1103019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The infiltration of suppressive myeloid cells into the tumor microenvironment restrains anti-tumor immunity. However, cytokines may alter the function of myeloid lineage cells to support tumor rejection, regulating the balance between pro-and anti-tumor immunity. In this study, it is shown that effector cytokines secreted by adoptively transferred T cells expressing a chimeric Ag receptor (CAR) shape the function of myeloid cells to promote endogenous immunity and tumor destruction. Mice bearing the ovarian ID8 tumor were treated with T cells transduced with a chimeric NKG2D receptor. GM-CSF secreted by the adoptively transferred T cells recruited peripheral F4/80(lo)Ly-6C(+) myeloid cells to the tumor microenvironment in a CCR2-dependent fashion. T cell IFN-gamma and GM-CSF activated local, tumor-associated macrophages, decreased expression of regulatory factors, increased IL-12p40 production, and augmented Ag processing and presentation by host macrophages to Ag-specific T cells. In addition, T cell-derived IFN-gamma, but not GM-CSF, induced the production of NO by F4/80(hi) macrophages and enhanced their lysis of tumor cells. The ability of CAR T cell therapy to eliminate tumor was moderately impaired when inducible NO synthase was inhibited and greatly impaired in the absence of peritoneal macrophages after depletion with clodronate encapsulated liposomes. This study demonstrates that the activation of host macrophages by CAR T cell-derived cytokines transformed the tumor microenvironment from immunosuppressive to immunostimulatory and contributed to inhibition of ovarian tumor growth. The Journal of Immunology, 2012, 188: 6389-6398.
引用
收藏
页码:6389 / 6398
页数:10
相关论文
共 57 条
[1]   Regression of experimental medulloblastoma following transfer of HER2-specific T cells [J].
Ahmed, Nabil ;
Ratnayake, Maheshika ;
Savoldo, Barbara ;
Perlaky, Laszlo ;
Dotti, Gianpietro ;
Wels, Winfried S. ;
Bhattacharjee, Meenakshi B. ;
Gilbertson, Richard J. ;
Shine, H. David ;
Weiss, Heidi L. ;
Rooney, Cliona M. ;
Heslop, Helen E. ;
Gottschalk, Stephen .
CANCER RESEARCH, 2007, 67 (12) :5957-5964
[2]   Tumor-specific granulocyte macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells [J].
Aruga, A ;
Shu, SY ;
Chang, AE .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (05) :317-324
[3]   Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer [J].
Barber, Amorette ;
Zhang, Tong ;
Sentman, Charles L. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (01) :72-78
[4]   Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment [J].
Barber, Amorette ;
Rynda, Agnieszka ;
Sentman, Charles L. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (11) :6939-6947
[5]   Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity [J].
Barber, Amorette ;
Sentman, Charles L. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (04) :2365-2372
[6]   Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer [J].
Barber, Arnorette ;
Zhang, Tong ;
DeMars, Leslie R. ;
Conejo-Garcia, Jose ;
Roby, Katherine F. ;
Sentman, Charles L. .
CANCER RESEARCH, 2007, 67 (10) :5003-5008
[7]   Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm [J].
Biswas, Subhra K. ;
Mantovani, Alberto .
NATURE IMMUNOLOGY, 2010, 11 (10) :889-896
[8]   Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 [J].
Brentjens, RJ ;
Latouche, JB ;
Santos, E ;
Marti, F ;
Gong, MC ;
Lyddane, C ;
King, PD ;
Larson, S ;
Weiss, M ;
Rivière, I ;
Sadelain, M .
NATURE MEDICINE, 2003, 9 (03) :279-286
[9]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[10]   STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules [J].
Coccia, EM ;
Del Russo, N ;
Stellacci, E ;
Testa, U ;
Marziali, G ;
Battistini, A .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (07) :1075-1083